Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis.
Li G, Chen H, Shen F, Smithson SB, Shealy GL, Ping Q, Liang Z, Han J, Adams AC, Li Y, Feng D, Gao B, Morita M, Han X, Huang TH, Musi N, Zang M.
Li G, et al. Among authors: gao b.
Hepatology. 2023 Nov 1;78(5):1506-1524. doi: 10.1097/HEP.0000000000000433. Epub 2023 May 3.
Hepatology. 2023.
PMID: 37129868
Free PMC article.